VALIANTLAB — Valiant Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- IN₹5.00bn
- IN₹5.45bn
- IN₹1.33bn
- 27
- 18
- 61
- 25
Annual balance sheet for Valiant Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | PROSPECTUS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 201 | 361 | 1,438 | 760 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1,124 | 905 | 498 | 744 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1,497 | 1,506 | 2,255 | 1,926 |
| Net Property, Plant And Equipment | 237 | 488 | 927 | 2,041 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 1,744 | 2,130 | 3,427 | 4,009 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 420 | 507 | 291 | 596 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1,029 | 1,125 | 1,058 | 1,665 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 715 | 1,005 | 2,369 | 2,343 |
| Total Liabilities & Shareholders' Equity | 1,744 | 2,130 | 3,427 | 4,009 |
| Total Common Shares Outstanding |